VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,315,000 | -38.5% | 22,770 | +7.9% | 1.14% | -35.7% |
| Q3 2015 | $3,764,000 | -14.6% | 21,100 | +6.3% | 1.77% | +12.3% |
| Q2 2015 | $4,410,000 | +11.8% | 19,850 | 0.0% | 1.58% | +11.4% |
| Q1 2015 | $3,943,000 | +119.1% | 19,850 | +57.8% | 1.41% | +77.9% |
| Q4 2014 | $1,800,000 | +39.3% | 12,580 | +27.7% | 0.80% | +42.0% |
| Q3 2014 | $1,292,000 | -44.9% | 9,850 | -47.0% | 0.56% | -34.5% |
| Q2 2014 | $2,346,000 | -4.3% | 18,600 | 0.0% | 0.86% | -9.8% |
| Q1 2014 | $2,452,000 | +12.3% | 18,600 | 0.0% | 0.95% | +10.2% |
| Q4 2013 | $2,184,000 | -10.3% | 18,600 | -20.3% | 0.86% | -12.1% |
| Q3 2013 | $2,436,000 | +18.9% | 23,350 | -1.9% | 0.98% | +8.9% |
| Q2 2013 | $2,049,000 | – | 23,800 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |